Induced pluripotent stem cell-derived conditioned medium (iPS-CM) could improve cell viability in many types of cells and may be a better alternative for the treatment of myocardial infarction. This study aimed to examine the influence of iPS-CM on anti-apoptosis and the proliferation of H9C2 cardiomyocytes and investigate the underlying mechanisms. H9C2 cardiomyocytes were exposed to 200 μmol/L hydrogen peroxide (H 2 O 2 ) for 24 hours with or without pre-treatment with iPS-CM. The ratio of apoptotic cells, the loss of mitochondrial membrane potential (△Ψm) and the levels of intracellular reactive oxygen species were analysed by flow cytometric analysis. The expression levels of BCL-2 and BAX proteins were analysed by Western blot.
| INTRODUC TI ON
In recent years, myocardial infarction has become one of the leading causes of mortality worldwide.
1 Myocardial infarction is defined as necrosis of cardiomyocytes as a result of prolonged ischaemia, which is responsible for heart failure, cardiac fibrosis and sudden death. 2, 3 Oxidative stress plays an important role in cardiomyocyte proliferation, apoptosis and differentiation. 4 Currently, stem cell therapies for myocardial infarction have become promising alternatives to repair and regenerate injured tissues, and their applications are being extensively studied in various diseases. [5] [6] [7] [8] [9] [10] [11] Induced pluripotent stem cells (iPSCs), which can be directly obtained from adult cells using reprogramming factors (Oct 3/4, Sox2, Klf4 and c-Myc), 12 resemble embryonic stem cells with the abilities of self-renewal and differentiation into the three germ layers. 13 However, iPSCs have no immune rejection and ethical issues, which offer an attractive platform for disease model, pharmaceutical screening, and so on. 14, 15 So far, iPSCs have been successfully differentiated into cardiomyocytes. 16, 17 and can achieve in situ regeneration in infracted adult mouse hearts. 18 However, there are risks of tumorigenesis in rat hearts after cell transplantation. 19, 20 Conditioned medium could affect cell functions and viability via biologically active components. It has been reported that basic fibroblast growth factor (bFGF), nerve growth factor, hepatocyte growth factor, vascular endothelial growth factor (VEGF), insulinlike growth factor (IGF-1) and brain-derived neurotrophic factor could be secreted in the supernatant of cultured stem cells, which could improve cell viability. [21] [22] [23] Neel and Singla reported that iPSderived conditioned medium (iPS-CM) could reduce the occurrence of cardiac apoptotic nuclei in a diabetic cardiomyopathy rat model. 8 Lian et al showed that iPS-CM improved the proliferation and anti-apoptotic abilities of human adipose-derived stem cells. 24 Zhang et al concluded that paracrine factors of iPSCs could inhibit stress-induced senescence of H9C2 cardiomyocytes by inhibiting the p53-p21 and p16-pRb pathways. 25 The stimulation of cell proliferation and anti-apoptosis caused by iPS-CM is mainly because of the secreted cytokines that do not cause tumour formation. 8, [24] [25] [26] [27] There is the report that showed iPSCs and iPS-CM have similar therapeutic effects on lung injury through the same signalling pathway. 26 Therefore, iPS-CM could be used to treat myocardial infarction.
However, it is imperative to understand how and which factors of iPS-CM affect cardiomyocyte viability and functions prior to of myocardial infarction therapy.
In this study, we investigated the effects of iPS-CM on the proliferation and H 2 O 2 -induced apoptosis of H9C2 cardiomyocytes and evaluated the influences of iPS-CM on cell senescence and oxidative stress. Moreover, the potential mechanisms underlying the effects of iPS-CM on H9C2 cardiomyocytes were explored. This study aimed to develop an effective method to improve the activities of cardiomyocytes and offered a potential therapeutic approach for myocardial infarction. 
| MATERIAL S AND ME THODS

| Materials
H9C2
| Cell culture
H9C2 cardiomyocytes were cultured in medium (DMEM-HG) containing High-Glucose Dulbecco's Modified Eagle's Medium, 10%
FBS, and 1% penicillin and streptomycin. The culture conditions were maintained at 37°C in a 5% CO 2 incubator. The cells were subcultured at confluence.
| Preparation of iPS-CM
Human iPSCs were acquired from the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences. iPSCs were produced from the umbilical cord matrix and amniotic mesenchymal cells through the transduction of the retroviral factors Oct4, Sox2, c-Myc and Klf4. 28 Previously, established protocols were followed to culture the iPSCs. 29 Briefly, culture dishes were coated with 1%
Matrigel at least 30 minutes before cell seeding. Then the iPSCs were cultured in mTeSR1 medium in a 37°C incubator with 5% CO 2 .
Every 6 days, the iPSCs were subcultured using 0.05% trypsin-EDTA at 37°C for 5 minutes, and then seeded onto 1% Matrigel-coated culture plates. The supernatant of iPSCs was derived from the mTeSR1 medium cultured with iPSCs for 1 day. The supernatant was filtered (using a 0.22 μm filter) to remove dead cells and cell debris. The supernatant was then stored at −80°C for at least 2 weeks. The iPSC supernatant was mixed with DMEM-HG at a ratio of 1:2 to obtain iPS-CM. 
| CCK-8 assay
| TUNEL staining
The TUNEL assay was conducted to detect cell apoptosis using an in situ Cell Death Detection kit according to the manufacturer's in- were incubated in permeabilisation solution (0.1% Triton X-100) for 2 minutes on ice and treated with TdT/dUTP FITC labelling reaction mixture for 1 hour at 37°C in the dark, followed by three rinses with PBS. Cell nuclei were positive if they were labelled with FITC (green), whereas DAPI staining indicated the cell nucleus under the florescence microscope. The positive staining cells were counted using
Image-Pro Plus 6.0 software.
| Annexin V and PI assay
Annexin V and PI assays were conducted to measure the apop- 
| Measurement of mitochondrial membrane potential (Δψm)
The mitochondrial membrane potential (△Ψm) was measured using 
| Cell cycle assay
H9C2 cardiomyocytes (1 × 10 5 cells/well) were cultured in 6-well plates with DMEM-HG, iPS-CM and DMEM-HG+bFGF (30 ng/mL).
The cells were incubated for 24 hours at 37°C in a 5% CO 2 incubator. The cells were then harvested and fixed in 75% ethanol at 4°C
overnight. The following day, the cells were washed with PBS, and stained with PI in the dark for 30 minutes at room temperature. The stained cells were analysed using flow cytometry. TA B L E 1 Antibodies the xanthine oxidase method, with absorbance set at 450 nm. The GSH levels were measured based on the Ellman method. 30 The cell homogenate was mixed with reaction buffer (pH 8.0) and 5, 5′-dithiobis-(2-nitrobenzoic acid) for 5 minutes. The colour change was measured at a wavelength of 412 nm. All values were normalised according to the total protein concentration of the respective samples.
| EdU staining
| Measurement of MDA, SOD and GSH
| Enzyme-linked immunosorbent assay
An enzyme-linked immunosorbent assay (ELISA) kit was used to determine the levels of bFGF in DMEM-HG, iPS-CM and mTeSR1.
Briefly, 200 μL samples and 50 μL assay diluent were added to precoated wells of 96-well plates, and incubated at room temperature for 2 hours. The plates were then washed five times with washing buffer. Each well was treated with 100 μL of peroxidase-conjugated IgG anti-bFGF solution for 2 hours at room temperature. The plates were washed again five times with washing buffer. Then, 100 μL of substrate buffers were added into each well and incubated for 30 minutes at room temperature in the dark. Finally, the enzyme reaction was quenched with 50 μL of stop solution. The assays were analysed using a microplate reader at a wavelength of 550 nm with a correction wavelength of 450 nm.
| Statistical analysis
The collected data were statistically analysed using GraphPad Prism software (version 6; GraphPad Software Inc., San Diego, CA, USA).
Comparisons of different groups were performed using one-way F I G U R E 1 Exploration the optimal proportion of DMEM-HG:iPS-supernatant and apoptosis model of H 2 O 2 -induced H9C2 cardiomyocytes. A, The proliferation viabilities of H9C2 cardiomyocytes in different proportion of DMEM-HG:iPS-supernatant or mTeSR1:DMEM-HG were analysed by CCK-8. B, The TUNEL staining of H9C2 cardiomyocytes exposed to H 2 O 2 at different concentrations under an inverted fluorescence microscope. C, The quantity of positive cells (green fluorescence) using Image-Pro Plus 6.0 software. Mean ± SE, n = 5. *P < 0.05, **P < 0.01 designate significant differences when compared to control (1:0 or 0:1). The n.s designates no significant difference. Scale bars 100 μm ANOVA followed by Tukey's test. The values were expressed as the mean ± SD, and P < 0.05 was considered to be statistically significant. was selected as the optimal concentration for the following apoptosis model ( Figure 1C ).
| RE SULTS
| The optimal concentration of iPS-CM and
| iPS-CM inhibited H 2 O 2 -induced apoptosis of H9C2 cardiomyocytes
Annexin V and PI assays were used to evaluate apoptosis in dif- F I G U R E 2 iPS-CM inhibited the apoptosis of H 2 O 2 -induced H9C2 cardiomyocytes. A, Annexin V and propidium iodide (PI) assay was used to analyse the cell apoptosis in different groups. B, Quantification of the Annexin V and PI assay. Mean ± SE, n = 3. *P < 0.05, **P < 0.01, ***P < 0.001, designate significant differences. The n.s designates no significant difference F I G U R E 3 iPS-CM inhibited the loss of mitochondrial membrane potential (△Ψm) in H 2 O 2 -induced H9C2 cardiomyocytes. A, Mitochondrial membrane potential (△Ψm) assay was used to analyse the loss of △Ψm in different groups. B, Quantification of △Ψm. Mean ± SE, n = 3. *P < 0.05, **P < 0.01 designate significant differences. The n.s designates no significant difference F I G U R E 4 iPS-CM inhibited the generation of intracellular reactive oxygen species (ROS) in H 2 O 2 -induced H9C2 cardiomyocytes. A, Induced reactive oxygen species (ROS) assay was used to analyse the generation of ROS in different groups. B, Quantification of intracellular ROS. Mean ± SE, n = 3. *P < 0.05, **P < 0.01 designate significant differences. The n.s designates no significant difference cardiomyocytes, and bFGF added to DMEM-HG also rescued H 2 O 2 -treated H9C2 cardiomyocytes (Figure 2A treatment increased noticeably compared with that of DMEM-HG and iPS-CM groups, and was inhibited by iPS-CM or bFGF treatments ( Figure 3A) . The data showed that the ratios of JC-1-green/ red in the DMEM-HG and iPS-CM groups were 7.87 ± 0.45% and 6.70 ± 0.38%, respectively, which were less than those of the Mean ± SE, n = 3. *P < 0.05, **P < 0.01 , ***P < 0.001 designate significant differences. The n.s designates no significant difference. Scale bars 100 μm
| The effects of iPS-CM on BAX and BCL-2 expression in H 2 O 2 -treated H9C2 cardiomyocytes
To investigate the potential molecular mechanisms involved in the with different treatments. Mean ± SE, n = 3. *P < 0.05, **P < 0.01, ***P < 0.001, designate significant differences. The n.s designates no significant difference. Scale bars 100 μm in the DMEM-HG+bFGF+H 2 O 2 group was less than that in the DMEM-HG+H 2 O 2 group but was greater than that in the DMEM-HG, iPS-CM and iPS-CM+H 2 O 2 groups ( Figure 5A ). Figure 5B ).
These results indicated that iPS-CM or bFGF protected H9C2 cardiomyocytes from apoptosis by suppressing the expression of BAX while promoting the expression of BCL-2.
| iPS-CM promoted the proliferation of H9C2 cardiomyocytes
A cell cycle assay was used to determine the cell proliferation in the different groups. Cell proliferation occurs in the S and G2 phases. iPS-CM and bFGF promoted the proliferation of H9C2 cardiomyocytes.
Moreover, iPS-CM could also promote H9C2 cardiomyocyte prolif- HG+bFGF group were also less than those in the iPS-CM group as
The potential mechanisms underlying the promotion of H9C2 cardiomyocyte anti-apoptosis by iPS-CM. A, Quantification of the bFGF levels of medium in different groups using ELISA. B, Assessment of protein expression levels of LC3 I/II, Beclin-1, P62 and P53 in different groups using Western blot assays. C, Quantification of Western blot assays. Mean ± SE, n = 3. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, designate significant differences. The n.s designates no significant difference well as the green fluorescent densities in the DMEM-HG+H 2 O 2 group were also less than those in the iPS-CM+H 2 O 2 group ( Figure 6E ).
These results suggested that iPS-CM could promote the proliferation of H9C2 cardiomyocytes even under the H 2 O 2 administration. Figure 7B ). Therefore, we deduced that iPS-CM or bFGF suppressed H 2 O 2 -induced cell senescence in H9C2 cardiomyocytes.
| iPS-CM inhibited H 2 O 2 -induced cell senescence and oxidative stress in H9C2 cardiomyocytes
In addition, H 2 O 2 -induced oxidative stress can be inhibited by antioxidants. SOD and GSH are natural antioxidants found in the cells.
These antioxidants likely protect cells from oxidative stress. However, MDA is the end-product of lipid peroxidation and therefore can be found at high levels in the state of oxidative stress. As shown in Figure 7C , compared with the DMEM-HG and iPS-CM groups, H 2 O 2 treatment led to a significant increase in MDA levels. However, iPS-CM and bFGF significantly decreased the H 2 O 2 -induced MDA levels.
Furthermore, the levels of the antioxidant SOD and GSH were high in the DMEM-HG and iPS-CM groups. However, these levels considerably decreased when H9C2 cardiomyocytes were treated with H 2 O 2 alone, and iPS-CM or bFGF treatment could remit the loss of antioxidant SOD and GSH ( Figure 7D,E) . These results demonstrated that iPS-CM or bFGF inhibited H 2 O 2 -induced oxidative stress in H9C2 cardiomyocytes.
| The potential mechanism underlying the promotion of H9C2 cardiomyocyte anti-apoptosis and proliferation by iPS-CM
To elucidate the underlying mechanism of the anti-apoptotic and proliferative properties of iPS-CM on H9C2 cardiomyocytes, we first analysed the levels of different growth factors, such as bFGF, IGF-1 and VEGF in DMEM-HG, iPS-CM and mTeSR1 using ELISA.
Only bFGF, but not IGF-1 and VEGF (data not shown), showed significant differences among these groups, and the level of bFGF in iPS-CM was significantly greater than that in DMEM-HG or mTeSR1
( Figure 8A ). Based on this result, exogenous bFGF (30 ng/mL) was added to the DMEM-HG to establish a new group that mimicked the iPS-CM group, and the underlying signalling pathways were further investigated.
To to the iPS-CM, the expression of those proteins was down-regulated ( Figure 9B ). The β-catenin is a key downstream effector in the Wnt signalling pathway. Phosphorylation at ser675 induces β-catenin accumulation in the nucleus and increases its transcriptional activity.
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Based on these results, we might deduce that iPS-CM partially relied on endogenous bFGF to promote the proliferation of H9C2 cardiomyocytes through activation of the Wnt/β-catenin signalling pathway. A schematic summary of the mechanisms underlying the promotion of the anti-apoptotic and proliferative characteristics of H9C2 cardiomyocytes induced by iPS-CM is illustrated in Figure 9C .
The potential mechanisms underlying the promotion of H9C2 cardiomyocyte proliferation by iPS-CM. A, Assessment of protein expression levels of p-β-catenin (ser 675), β-catenin (nuclear protein), β-catenin (cytosolic protein), Cyclin D1, c-Myc and Survivin in different groups using Western blot assays. B, Quantification of Western blot assays. C, Diagram of the potential mechanisms underlying the promotion of H9C2 cardiomyocytes anti-apoptosis and proliferation by iPS-CM. Mean ± SE, n = 3. *P < 0.05, **P < 0.01, ***P < 0.001, designate significant differences. The n.s designates no significant difference Previous studies have shown that the proliferative ability of iPS-CM is attributed to the products secreted by iPSCs in culture medium. 29 Guo et al showed that the levels of bFGF and Activin A in iPS-CM were greater than in fresh mTeSR1 medium. 29 Villageois et al found that Activin A, which was secreted by hASCs isolated from various fat deposits of donors with different ages, promoted human multipotent adipose-derived stem cell proliferation and adipocyte differentiation. 45 In our study, bFGF levels in iPS-CM were also significantly greater than those in DMEM-HG and mTeSR1, which were determined using an ELISA assay. Based on this result, we added exogenous bFGF to DMEM-HG to mimic the function of iPS-CM.
| D ISCUSS I ON
Apoptosis is defined as highly regulated, programmed cell death that requires much energy and plays a key role in a variety of biological systems. Saraste et al showed that in myocardial samples obtained from acute myocardial infarction patients, a subset of cardiomyocytes underwent apoptosis. 46 Apoptosis was more prominent in the border zones of recent infarctions. [47] [48] [49] Recently, increasing attention has been focused on autophagy flux, which is the progression of autophagosome formation to cargo delivery and degradation in lysosomes caused by lysosomal proteases. 59, 60 Autophagy flux can be activated by cells to protect against apoptosis and inflammation under stress. 32, 61 It is well known that LC3 and Beclin-1 are involved in the progression of autophagosome formation, while P62 is an endogenous substrate of the autophagic process, which is considered a marker of autophagic flux, and the accumulation of P62 indicates disrupted autophagy flux. 62 Our results
showed that iPS-CM enhanced the expression levels of the autophagic proteins LC3 and Beclin-1, and decreased the accumulation of P62 and the apoptotic protein P53 under oxidative stress. These effects were reversed by LY294002, which is an inhibitor of autophagy flux. 33 Moreover, exogenous bFGF added to DMEM-HG activated autophagy flux by up-regulating the expression of LC3 and Beclin-1 and down-regulating the expression of P62 and P53 in H 2 O 2 -treated H9C2 cardiomyocytes. These results suggested that iPS-CM acted as a potential agonist of autophagy flux to inhibit the apoptosis of H 2 O 2 -treated H9C2 cardiomyocytes, which might be partially attributed to the endogenous bFGF. The Wnt/β-catenin signalling pathway is the classical pathway that regulates cell proliferation. 34 A closely related report has demonstrated that XAV939, an inhibitor of the Wnt/β-catenin signalling pathway, counteracted the proliferation of preterm umbilical cord MSCs (UC-MSCs) compared to term UC-MSCs. 63 In this study, we demonstrated that iPS-CM up-regulated the levels of p-β-catenin (ser 675), β-catenin (nuclear protein) other than β-catenin (cytosolic protein) and its target proteins Cyclin D1, c-Myc as well as Survivin. These effects of iPS-CM were inhibited by XAV-933.
Furthermore, exogenous bFGF added to DMEM-HG also up-regulated the expression of these proteins. These results indicated that iPS-CM effectively promoted the proliferation of H9C2 cardiomyocytes by activation of the Wnt/β-catenin signalling pathway, which might be partially attributed to endogenous bFGF.
In conclusion, our study demonstrated that iPS-CM might par- to improve the cardiomyocyte activities, and suggest that iPS-CM might be a potential therapeutic approach that might benefit patients with myocardial infarction. 
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